CNS Pharmaceuticals, Inc.

( )
CNSP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.57%177.750.7%$1152.45m
LLYEli Lilly & Co. -0.92%367.001.1%$1126.70m
MRKMerck & Co., Inc. -0.57%109.200.7%$1027.30m
PFEPfizer Inc. -0.86%50.700.9%$983.27m
ABBVAbbVie, Inc. -0.67%160.501.9%$860.26m
BMYBristol-Myers Squibb Co. -1.06%80.011.1%$763.48m
AZNAstraZeneca Plc -0.53%67.981.0%$356.23m
HZNPHorizon Therapeutics Plc 2.25%103.155.4%$316.17m
IDXXIDEXX Laboratories, Inc. -2.46%428.363.9%$224.32m
CTLTCatalent, Inc. -1.63%51.391.9%$210.20m
GSKGSK Plc 0.13%35.080.3%$189.99m
NVSNovartis AG -1.19%88.740.2%$184.11m
NVONovo Nordisk A/S -0.92%124.970.1%$171.23m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%220.258.0%$161.43m
RGENRepligen Corp. 0.00%188.176.7%$134.32m

Company Profile

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.